Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of BOTOX for crow's feet and glabellar lines
2010-020828-21Phase 3Completed
- Sponsor
- Allergan
- Start
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rhytides, Rhytidosis facialis and wrinkly skin syndrome (WSS) comparing BOTOX with Placebo (2 arms). Primary endpoints: Co-primary efficacy endpoints and Safety endpoints. Started Aug 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
rhytidesRhytidosis facialiswrinkly skin syndrome (WSS)
Beyond the preview
Go deeper on 2010-020828-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020828-21.